Alkem Laboratories appointed Mr. Chanakya Misra to a senior management position effective May 18, 2026.
The appointment was disclosed pursuant to SEBI LODR Regulation 30(2) via a formal stock exchange filing.
Mr. Misra brings over 25 years of experience in pharmaceuticals, public health, and rare diseases.
His term of appointment is for the duration of his employment with the company, as per his contract.